Takeda Pharmaceutical Company

E474950

Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.

Try in SPARQL Jump to: Statements Referenced by

Statements (48)

Predicate Object
instanceOf biopharmaceutical company
multinational corporation
public company
acquired Shire plc NERFINISHED
acquisitionOfShireCompletedIn 2019
coreTherapeuticArea gastroenterology
neuroscience
oncology
rare diseases
corporateSlogan Better Health, Brighter Future
country Japan
engagesIn global commercialization of medicines
manufacturing of pharmaceuticals
research and development of innovative medicines
focusesOn gastroenterology
neuroscience
oncology
plasma-derived therapies
rare diseases
vaccines
follows Takeda-ism values
foundedIn 1781
founder Chobei Takeda I NERFINISHED
hasNotableProductArea cancer treatments
central nervous system disorder treatments
gastrointestinal disease treatments
rare genetic disease treatments
hasRAndDCentersIn Europe NERFINISHED
Japan NERFINISHED
United States NERFINISHED
hasSubsidiary Shire plc NERFINISHED
headquartersLocation Japan NERFINISHED
Tokyo
industry biotechnology industry
pharmaceutical industry
legalForm Kabushiki gaisha
listedOn New York Stock Exchange
Tokyo Stock Exchange NERFINISHED
numberOfEmployees over 50,000
operatesIn more than 80 countries
revenueRanking one of the largest pharmaceutical companies in Asia
one of the largest pharmaceutical companies in the world
TakedaIsmValuesInclude Fairness
Honesty
Integrity
Perseverance
tradedAs NYSE:TAK NERFINISHED
TSE:4502 NERFINISHED

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Heptares Therapeutics collaboratesWith Takeda Pharmaceutical Company
Ariad Pharmaceuticals acquiredBy Takeda Pharmaceutical Company